GROUP ONE TRADING, L.P. - KARYOPHARM THERAPEUTICS INC ownership

KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 134 filers reported holding KARYOPHARM THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 5.01 and the average weighting 0.1%.

Quarter-by-quarter ownership
GROUP ONE TRADING, L.P. ownership history of KARYOPHARM THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$73,047
+2633.8%
54,513
+3551.2%
0.00%
Q2 2023$2,672
-77.9%
1,493
-52.0%
0.00%
Q1 2023$12,098
-98.4%
3,110
-97.4%
0.00%
-100.0%
Q4 2021$772,000
+183.8%
120,114
+157.5%
0.00%
Q3 2021$272,000
+455.1%
46,654
+875.4%
0.00%
Q2 2021$49,000
-91.2%
4,783
-91.0%
0.00%
-100.0%
Q1 2021$560,000
-57.2%
53,249
-37.0%
0.00%
-50.0%
Q4 2020$1,307,000
+299.7%
84,458
+276.7%
0.00%
+100.0%
Q3 2020$327,000
-7.4%
22,420
-38.8%
0.00%
-66.7%
Q3 2019$353,000
+578.8%
36,646
+321.3%
0.00%
Q2 2019$52,000
-70.1%
8,698
-70.8%
0.00%
-100.0%
Q1 2019$174,000
+56.8%
29,784
+261.2%
0.00%
+100.0%
Q1 2018$111,000
+117.6%
8,246
+9.2%
0.00%0.0%
Q2 2016$51,000
+70.0%
7,554
+125.4%
0.00%
Q1 2016$30,000
-90.2%
3,351
-85.4%
0.00%
-100.0%
Q4 2015$305,000
+224.5%
23,017
+157.8%
0.00%
+300.0%
Q3 2015$94,000
-71.7%
8,928
-26.8%
0.00%
-80.0%
Q2 2015$332,000
+42.5%
12,196
+60.5%
0.01%
+25.0%
Q1 2015$233,000
+194.9%
7,601
+260.9%
0.00%
+300.0%
Q4 2014$79,000
+132.4%
2,106
+115.6%
0.00%0.0%
Q3 2014$34,0009770.00%
Other shareholders
KARYOPHARM THERAPEUTICS INC shareholders Q3 2021
NameSharesValueWeighting ↓
Consonance Capital Management LP 7,180,700$137,941,00010.27%
Palo Alto Investors LP 4,299,901$82,601,0006.92%
Fairmount Funds Management LLC 562,351$10,803,0006.55%
Avoro Capital Advisors LLC 7,000,000$134,470,0004.54%
Pinz Capital Management, LP 8,820$1,694,0004.44%
Birchview Capital, LP 148,000$2,843,0002.52%
Elk Creek Partners, LLC 699,951$13,446,0002.31%
Parkman Healthcare Partners LLC 215,802$4,146,0001.92%
EAM Global Investors LLC 136,402$2,620,0001.53%
SPHERA FUNDS MANAGEMENT LTD. 550,000$10,566,0001.32%
View complete list of KARYOPHARM THERAPEUTICS INC shareholders